Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty

Glucokinase

Glucokinase is an enzyme that facilitates phosphorylation of glucose to glucose-6-phosphate. Glucokinase occurs in cells in the liver and pancreas of humans and most other vertebrates. In each of these organs it plays an important role in the regulation of carbohydrate metabolism by acting as a glucose sensor, triggering shifts in metabolism or cell function in response to rising or falling levels of glucose, such as occur after a meal or when fasting. Mutations of the gene for this enzyme can cause unusual forms of diabetes or hypoglycemia.Glucokinase (GK) is a hexokinase isozyme, related homologously to at least three other hexokinases. All of the hexokinases can mediate phosphorylation of glucose to glucose-6-phosphate (G6P), which is the first step of both glycogen synthesis and glycolysis.

POMHEX
T364912004714-34-3
Pomhex, a cell-permeable potent enolase inhibitor with anticancer activity, is used in the study of cancer lethality.Pomhex, a racemic mixture, is a potent and selective ENO2 inhibitor.Pomhex is inhibitory to the glycolytic process, and shows anticancer activity at low concentrations in an ENO1-deficient tumor model.Pomhex, a cell-permeable potent enolase inhibitor with anticancer activity, is a potent and selective ENO2 inhibitor.
  • $148
In Stock
Size
QTY
AP-III-a4
T67591177827-73-4
AP-III-a4 (ENOblock) (ENOblock) is the first nonsubstrate analogue inhibitor of enolase with IC50 of 0.576 μM.
  • $47
In Stock
Size
QTY
Kaempferitrin
T3386482-38-2
Kaempferitrin (Lespenephryl) has antidepressant-like effect related to the serotonergic system, principally 5-HT1A. Kaempferitrin exerts cytotoxic and antitumor effects against HeLa cells. Kaempferitrin stimulates glucose-metabolizing enzymes, promotes glucose homeostasis. Kaempferitrin exerts immunostimulatory effects on immune responses mediated by splenocytes, macrophages, PBMC and NK cells. Kaempferitrin induces cytotoxic effects to include: cell cycle arrest in G1 phase and apoptosis via the intrinsic pathway in a caspase-dependent pathway.
  • $43
In Stock
Size
QTY
RO-28-1675
T16793300353-13-3
RO-28-1675 is a direct and selective glucokinase activator that indirectly affects the activity of the GK GKRP (glucokinase regulatory protein) complex, with efficacy decreasing with increasing glucose concentration, and can be used in studies related to insulin secretion and type 2 diabetes.
  • $91
In Stock
Size
QTY
MitoPQ
T334121821370-28-8
MitoPQ (MitoParaquat) is a mitochondria-targeted small molecule compound that selectively enhances mitochondrial superoxide and hydrogen peroxide levels and inhibits insulin-stimulated glucose uptake and translocation of glucose transport protein 4 (GLUT4) to the plasma membrane in adipocytes and myotubes.MitoPQ can be used to MitoPQ can be used to study mitochondrial oxidative stress and regulated GLUT4 transporter.
  • $41
In Stock
Size
QTY
Dorzagliatin
T151591191995-00-2
Dorzagliatin (HMS5552) is a dual-acting glucokinase (GK) activator. It also improves glycaemic control and pancreatic β-cell function in type 2 diabetes.
  • $34
In Stock
Size
QTY
TargetMol | Inhibitor Sale
ML251
T643201486482-16-9
ML251 is a potent novel nanomolar inhibitor of T. brucei and T. cruzi phosphofructokinase[1]. ML251 inhibits T. brucei PFK (IC50=0.37 μM) and T. cruzi PFK (IC50=0.13 μM). ML251 can be used for the research of parasite[1].
  • $135
In Stock
Size
QTY
KAN0438757
T117411451255-59-6
KAN0438757 is a selective and potent inhibitor of the metabolic kinase [PFKFB3] with an IC50 of 0.19 μM.
  • $103
In Stock
Size
QTY
PFK-158
T31051462249-75-7
PFK-158 is an effective and specific inhibitor PFKFB3.
  • $30
In Stock
Size
QTY
TargetMol | Inhibitor Sale
TargetMol | Citations Cited
WAY-640509
T60048851185-20-1
WAY-640509 is a glucocerebrosidase inhibitor.
  • $117
In Stock
Size
QTY
ML198
T89861380716-06-2
ML198 is a novel activator and non-inhibitory chaperone of glucocerebrosidase. ML198 serves as a starting point to develop a novel approach towards small molecule treatment for patients suffering from Gaucher disease.
  • $41
In Stock
Size
QTY
TargetMol | Inhibitor Sale
AZ PFKFB3 26
T143651704740-52-2In house
AZ PFKFB3 26 is an effective and selective PFKFB3 inhibitor with an IC50 of 23 nM. The IC50s for PFKFB1 and PFKFB2 are 2.06 and 0.384 μM, respectively.
  • $30
In Stock
Size
QTY
Genz-123346 free base
T4049491833-30-8
Genz 123346 is an inhibitor of GL1 synthase that blocks the conversion of ceramide to GL1.
  • $43
In Stock
Size
QTY
TargetMol | Inhibitor Sale
SF2312
T28764107729-45-3
SF2312 is a natural phosphonate antibiotic produced by Actinobacillus microsporus and is a potent inhibitor of the glycolytic enzyme enolase.SF2312 has antimicrobial activity and inhibits bacterial growth against both Gram-negative and Gram-negative bacteria. SF2312 inhibits human recombinant ENO1 and ENO2.
  • $115
In Stock
Size
QTY
Palmitelaidic Acid
T1950010030-73-6
Palmitelaidic Acid (trans-Palmitoleic acid) is one of the most abundant fatty acids in serum and tissue.
  • $30
In Stock
Size
QTY
3PO
T2222318550-98-6
3PO is a small-molecule inhibitor of PFKFB3 (IC50: 22.9 μM), inhibiting the proliferation of several human malignant hematopoietic and adenocarcinoma cell lines (IC50: 1.4-24 μM). It suppresses glucose uptake, and decreases the intracellular concentration
  • $52
In Stock
Size
QTY
TargetMol | Inhibitor Sale
AMG-3969
TQ00551361224-53-4
AMG-3969 is an effective glucokinase-glucokinase regulatory protein interaction (GK-GKRP) disruptor (IC50: 4 nM).
  • $123
In Stock
Size
QTY
5MPN
T4056547208-82-2
5MPN is an orally active and selective inhibitor of 6-phosphofructokinase-2-kinase (PFKFB4) that competitively inhibits the F6P binding site and inhibits the proliferation of myeloma cells, and can be used in the study of myeloproliferative neoplasms.
    Inquiry
    YZ9
    T235526093-71-6
    Y29 is a potent PFKFB3 inhibitor with an IC50 of 0.183 µM, acting as a competitive inhibitor against Fru-6-P with a Ki of 0.094 µM[1].
    • $50
    In Stock
    Size
    QTY
    TargetMol | Inhibitor Sale
    Oxfendazole
    T071453716-50-0
    Oxfendazole (RS-8858), a broad spectrum benzimidazole anthelmintic, protects livestock against roundworm, strongyles and pinworms.
    • $31
    In Stock
    Size
    QTY
    AZD-1656
    T26712919783-22-5
    AZD-1656 is a glucokinase activator (GKA) that can cause dose-limiting hypoglycemia in normal animals used in embryofetal development studies and type 2 diabetes.
    • $84
    In Stock
    Size
    QTY
    PF-04937319
    T164791245603-92-2In house
    PF-04937319 is an activator of glucokinase (EC50 =154.4  μM). PF-04937319 maintains glucose-lowering efficacy while mitigating the risk of hypoglycemia observed with many other glucokinase activators. PF-04937319 can be used in research on the treatment of type 2 diabetes mellitus.
    • $38
    In Stock
    Size
    QTY
    Globalagliatin
    T31041234703-40-2In house
    Globalagliatin (LY2608204) has been used in trials studying the treatment of Diabetes Mellitus, Type 2.
    • $32
    In Stock
    Size
    QTY
    MK-0941 free base
    T12056752240-01-0
    MK-0941 free base is an orally active glucokinase activator with potent glucose-lowering activity, making it a potential therapeutic agent for type 2 diabetes.
    • $79
    In Stock
    Size
    QTY